Nuveen Asset Management LLC decreased its holdings in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 9.5% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,172,338 shares of the company's stock after selling 123,117 shares during the period. Nuveen Asset Management LLC owned approximately 0.69% of Option Care Health worth $27,198,000 as of its most recent filing with the Securities and Exchange Commission.
Several other large investors also recently made changes to their positions in OPCH. Wellington Management Group LLP boosted its holdings in shares of Option Care Health by 84.6% in the fourth quarter. Wellington Management Group LLP now owns 18,325,123 shares of the company's stock worth $425,143,000 after buying an additional 8,400,208 shares during the period. Norges Bank acquired a new position in shares of Option Care Health in the fourth quarter worth about $60,219,000. Freestone Grove Partners LP acquired a new position in shares of Option Care Health in the fourth quarter worth about $17,487,000. Dimensional Fund Advisors LP boosted its holdings in shares of Option Care Health by 17.4% in the fourth quarter. Dimensional Fund Advisors LP now owns 3,988,051 shares of the company's stock worth $92,518,000 after buying an additional 591,042 shares during the period. Finally, Victory Capital Management Inc. boosted its holdings in shares of Option Care Health by 31.1% in the fourth quarter. Victory Capital Management Inc. now owns 2,125,433 shares of the company's stock worth $49,310,000 after buying an additional 503,840 shares during the period. Institutional investors own 98.05% of the company's stock.
Insider Activity
In other news, insider Michael Bavaro sold 30,996 shares of Option Care Health stock in a transaction that occurred on Friday, February 28th. The shares were sold at an average price of $33.26, for a total value of $1,030,926.96. Following the transaction, the insider now owns 44,974 shares of the company's stock, valued at $1,495,835.24. This trade represents a 40.80% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders own 0.64% of the company's stock.
Wall Street Analyst Weigh In
Several research analysts have commented on OPCH shares. JMP Securities reiterated a "market outperform" rating and issued a $36.00 target price on shares of Option Care Health in a report on Tuesday, April 22nd. UBS Group upgraded shares of Option Care Health from a "neutral" rating to a "buy" rating and raised their target price for the stock from $38.00 to $40.00 in a report on Wednesday, April 30th. JPMorgan Chase & Co. raised their price target on shares of Option Care Health from $40.00 to $41.00 and gave the stock an "overweight" rating in a report on Thursday, March 6th. Finally, Barrington Research restated an "outperform" rating and set a $38.00 price target on shares of Option Care Health in a report on Wednesday, April 30th. One investment analyst has rated the stock with a hold rating and seven have issued a buy rating to the company. According to data from MarketBeat, Option Care Health currently has a consensus rating of "Moderate Buy" and an average target price of $35.50.
Read Our Latest Stock Report on OPCH
Option Care Health Stock Up 2.2%
Shares of OPCH stock traded up $0.70 during trading on Tuesday, hitting $32.11. 369,176 shares of the company were exchanged, compared to its average volume of 1,857,015. The firm has a market capitalization of $5.26 billion, a price-to-earnings ratio of 26.97, a P/E/G ratio of 2.30 and a beta of 0.76. The business's 50-day simple moving average is $32.93 and its 200 day simple moving average is $29.45. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73. Option Care Health, Inc. has a twelve month low of $21.39 and a twelve month high of $35.53.
Option Care Health (NASDAQ:OPCH - Get Free Report) last issued its quarterly earnings data on Tuesday, April 29th. The company reported $0.40 earnings per share for the quarter, beating the consensus estimate of $0.36 by $0.04. The firm had revenue of $1.33 billion for the quarter, compared to analyst estimates of $1.26 billion. Option Care Health had a net margin of 4.37% and a return on equity of 15.30%. The company's revenue for the quarter was up 16.3% on a year-over-year basis. During the same quarter last year, the firm earned $0.26 earnings per share. As a group, analysts forecast that Option Care Health, Inc. will post 1.22 EPS for the current fiscal year.
Option Care Health Company Profile
(
Free Report)
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
See Also

Before you consider Option Care Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Option Care Health wasn't on the list.
While Option Care Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.